China Justice Observer

中司观察

EnglishArabicChinese (Simplified)DutchFrenchGermanHindiItalianJapaneseKoreanPortugueseRussianSpanishSwedishHebrewIndonesianVietnameseThaiTurkishMalay

China Enhances Sci-Tech Ethics Oversight

Wed, 29 Nov 2023
Categories: China Legal Trends

On 9 Oct. 2023, ten Chinese government departments, including the Ministry of Science and Technology, the Ministry of Education, and the Ministry of Industry and Information Technology, jointly issued the “Measures for Scientific and Technological Ethics Review (for Trial Implementation)” (科技伦理审查办法(试行), hereinafter the “Measures”)

The Measures aim to regulate the ethical review of scientific research, technology development, and other scientific and technological (“sci-tech”) activities, so as to strengthen the prevention and control of sci-tech ethical risks and promote responsible innovation.

According to the Measures, sci-tech activities that shall be subject to sci-tech ethical review include:

  1. sci-tech activities involving human research participants, including human testing, investigation, observation, and other research activities, and sci-tech activities utilizing human biological samples and personal information, among others;
  2. sci-tech activities involving laboratory animals;
  3. sci-tech activities that do not directly involve humans or laboratory animals but may pose ethical risks and challenges to areas such as life and health, ecology and the environment, public order, sustainable development; and
  4. other sci-tech activities that shall be subject to sci-tech ethical review in accordance with laws.

The Measures include a list of sci-tech activities that require ethical review in the Annex, such as:

  1. research on synthesizing new species with significant impact;
  2. related research on the introduction of human stem cells into animal embryos or fetuses and further development into individuals in the animal uterus;
  3. basic research that alters the genetic material or genetic rules of human germ cells, fertilized eggs, and pre-implantation embryo cells;
  4. clinical research of invasive brain-computer interface for the treatment of neurological and psychiatric disorders;
  5. research and development of human-machine integration systems that have strong influences on human subjective behaviors, psychological emotions, and life and health, among others;
  6. research and development of algorithmic models, applications, and systems with the ability to mobilize the public and guide social consciousness; and
  7. research and development of highly autonomous decision-making systems for scenarios involving safety and personal health risks.

 

 

Photo by Stefan Wagener on Unsplash

Contributors: CJO Staff Contributors Team

Save as PDF

You might also like

China Intensifies Crackdown on Cross-Border Telecom Fraud

In July 2024, China's Supreme People’s Procuratorate (SPP), Supreme People’s Court (SPC), and the Ministry of Public Security released ten typical cases to highlight their intensified efforts to combat cross-border telecom and online fraud, emphasizing organized crime and emerging technologies.

China's Clean Energy Progress Report (2024)

China's 2024 white paper titled “China’s Energy Transition” shows clean energy now makes up 58.2% of installed power capacity, with wind and solar increasing tenfold over a decade, and clean energy consumption rising from 15.5% to 26.4% of total energy use.

SPC Releases Typical Cases on Foreign Law Ascertainment

In July 2024, China's Supreme People's Court (SPC) issued its first batch of typical cases to illustrate the application of foreign laws, aiming to enhance the judiciary's understanding of its 2023 judicial interpretation on ascertainment of foreign law.

China Updates Regulation for State Secrets Law

In June 2024, China revised the implementing regulation for its State Secrets Law, enhancing classification procedures, personnel confidentiality management, and secrecy inspection standards.

Chinese Court Refuses to Recognize Russian Judgment Due to Due Process

In 2020, a local Chinese court in Beijing ruled against the recognition and enforcement of a Russian monetary judgment on the grounds that the party in absentia had not been properly summoned (the case of Chepetsky Mechanical Plant Joint-Stock Company (2020) Jing 04 Xie Wai Ren No. 2).

China's New Company Law: Enforcing Paid-in Capital Rules

China's revised Company Law introduces a paid-in capital system, requiring shareholders to fully contribute their subscribed capital within five years, with a three-year transition period for existing companies to adjust their capital contributions.

China Issues Regulation on Rare Earth Administration

In April 2024, China introduced its first comprehensive regulation on rare earth management, addressing production, circulation, and reserves to ensure a regulated market and sustainable industry development.

China Revises Frontier Health and Quarantine Law

In June 2024, China revised its Frontier Health and Quarantine Law (国境卫生检疫法) to enhance measures against infectious disease transmission, including new quarantine protocols and medical priority for affected individuals.